In silico design and validation of a time-varying PID controller for an artificial pancreas with intraperitoneal insulin delivery and glucose sensing
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Type 1 diabetes (T1D) is a chronic autoimmune disease featured by the loss of beta cell function and the need for lifetime insulin replacement. Over the recent decade, the use of automated insulin delivery systems (AID) has shifted the paradigm of treatment: the availability of continuous subcutaneous (SC) glucose sensors to guide SC insulin delivery through a control algorithm has allowed, for the first time, to reduce the daily burden of the disease as well as to abate the risk for hypoglycemia. AID use is still limited by individual acceptance, local availability, coverage, and expertise. A major drawback of SC insulin delivery is the need for meal announcement and the peripheral hyperinsulinemia that, over time, contributes to macrovascular complications. Inpatient trials using intraperitoneal (IP) insulin pumps have demonstrated that glycemic control can be improved without meal announcement due to the faster insulin delivery through the peritoneal space. This calls for novel control algorithms able to account for the specificities of IP insulin kinetics. Recently, our group described a two-compartment model of IP insulin kinetics demonstrating that the peritoneal space acts as a virtual compartment and IP insulin delivery is virtually intraportal (intrahepatic), thus closely mimicking the physiology of insulin secretion. The FDA-accepted T1D simulator for SC insulin delivery and sensing has been updated for IP insulin delivery and sensing. Herein, we design and validate—in silico—a time-varying proportional integrative derivative controller to guide IP insulin delivery in a fully closed-loop mode without meal announcement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“and to design and validate a proportional-integral-derivative (PID) controller to guide IP insulin delivery in a fully closed-loop mode that does not require meal announcement.144”
From Developing the UVA/Padova Type 1 Diabetes Simulator: Modeling, Validation, Refinements, and Utility (2023) · cites this paper as [144]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
Self-citationPID control system analysis, design, and technology
Ang, K. H., Chong, G., & Li, Y. (2005) · IEEE Transactions on Control Systems Technology · doi:10.1109/tcst.2005.847331 · Cited by 2,983
Gregory, G. A., Robinson, T. I. G., Linklater, S. E., Wang, F., Colagiuri, S., de Beaufort, C., Donaghue, K. C., Harding, J. L., Wander, P. L., Zhang, X., et al. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00218-2 · Cited by 1,149
Glycemic Control and Excess Mortality in Type 1 Diabetes
Lind, M., Svensson, A.-M., Kosiborod, M., Gudbjörnsdottir, S., Pivodic, A., Wedel, H., Dahlqvist, S., Clements, M., & Rosengren, A. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408214 · Cited by 964
Feasibility of Automating Insulin Delivery for the Treatment of Type 1 Diabetes
Steil, G. M., Rebrin, K., Darwin, C., Hariri, F., & Saad, M. F. (2006) · Diabetes · doi:10.2337/db06-0419 · Cited by 473
Phillip, M., Nimri, R., Bergenstal, R. M., Barnard-Kelly, K., Danne, T., Hovorka, R., Kovatchev, B. P., Messer, L. H., Parkin, C. G., Ambler-Osborn, L., et al. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac022 · Cited by 443
Self-citationClosed-Loop Artificial Pancreas Systems: Engineering the Algorithms
Doyle, F. J., Huyett, L. M., Lee, J. B., Zisser, H. C., & Dassau, E. (2014) · Diabetes Care · doi:10.2337/dc13-2108 · Cited by 394
The UVA/Padova Type 1 Diabetes Simulator Goes From Single Meal to Single Day
Visentin, R., Campos-Náñez, E., Schiavon, M., Lv, D., Vettoretti, M., Breton, M., Kovatchev, B. P., Dalla Man, C., & Cobelli, C. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818757747 · Cited by 280
Self-citationRenard, E., Place, J., Cantwell, M., Chevassus, H., & Palerm, C. C. (2010) · Diabetes Care · doi:10.2337/dc09-1080 · Cited by 176
Control-Relevant Models for Glucose Control Using A Priori Patient Characteristics
van Heusden, K., Dassau, E., Zisser, H. C., Seborg, D. E., & Doyle, F. J. (2012) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2011.2176939 · Cited by 160
ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin delivery
Sherr, J. L., Schoelwer, M., Dos Santos, T. J., Reddy, L., Biester, T., Galderisi, A., van Dyk, J. C., Hilliard, M. E., Berget, C., & DiMeglio, L. A. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13421 · Cited by 152
Self-citationMPC based Artificial Pancreas: Strategies for individualization and meal compensation
Soru, P., Nicolao, G. D., Toffanin, C., Man, C. D., Cobelli, C., & Magni, L. (2012) · Annual Reviews in Control · doi:10.1016/j.arcontrol.2012.03.009 · Cited by 130
Self-citationCircadian Variability of Insulin Sensitivity: Physiological Input for In Silico Artificial Pancreas
Visentin, R., Dalla Man, C., Kudva, Y. C., Basu, A., & Cobelli, C. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0192 · Cited by 113
Self-citationToward a Run-to-Run Adaptive Artificial Pancreas: In Silico Results
Toffanin, C., Visentin, R., Messori, M., Palma, F. D., Magni, L., & Cobelli, C. (2018) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2017.2652062 · Cited by 107
Self-citationPhysiologic insulin delivery with insulin feedback: A control systems perspective
Palerm, C. C. (2010) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2010.06.007 · Cited by 104
Design and Evaluation of a Robust PID Controller for a Fully Implantable Artificial Pancreas
Huyett, L. M., Dassau, E., Zisser, H., & Doyle, F. J. (2015) · Industrial & Engineering Chemistry Research · doi:10.1021/acs.iecr.5b01237 · Cited by 103
Dassau, E., Renard, E., Place, J., Farret, A., Pelletier, M., Lee, J., Huyett, L. M., Chakrabarty, A., Doyle, F. J., & Zisser, H. C. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12999 · Cited by 94
Burnett, D. R., Huyett, L. M., Zisser, H. C., Doyle, F. J., & Mensh, B. D. (2014) · Diabetes · doi:10.2337/db13-1649 · Cited by 52
Multivariate learning framework for long‐term adaptation in the artificial pancreas
Shi, D., Dassau, E., & Doyle, F. J. (2018) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10119 · Cited by 41
Linear Model Identification for Personalized Prediction and Control in Diabetes
Faccioli, S., Facchinetti, A., Sparacino, G., Pillonetto, G., & Favero, S. D. (2021) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2021.3101589 · Cited by 30
Self-citationToffanin, C., Magni, L., & Cobelli, C. (2021) · IEEE Transactions on Medical Robotics and Bionics · doi:10.1109/tmrb.2021.3075775 · Cited by 22
Self-citationChakrabarty, A., Gregory, J. M., Moore, L. M., Williams, P. E., Farmer, B., Cherrington, A. D., Lord, P., Shelton, B., Cohen, D., Zisser, H., et al. (2019) · Journal of Process Control · doi:10.1016/j.jprocont.2019.01.002 · Cited by 21
Design and in silico evaluation of an intraperitoneal–subcutaneous (IP–SC) artificial pancreas
Lee, J. J., Dassau, E., Zisser, H., & Doyle, F. J. (2014) · Computers & Chemical Engineering · doi:10.1016/j.compchemeng.2014.02.024 · Cited by 19
Wolpert, H. A., Kavanagh, M., Atakov-Castillo, A., & Steil, G. M. (2015) · Diabetic Medicine · doi:10.1111/dme.12823 · Cited by 15
Lo Presti, J., Galderisi, A., Doyle, F. J., Zisser, H. C., Dassau, E., Renard, E., Toffanin, C., & Cobelli, C. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221076559 · Cited by 12
Self-citationPhysiologic Insulin Delivery with Insulin Feedback: A Control Systems Perspective
Palerm, C. C. (2009) · IFAC Proceedings Volumes · doi:10.3182/20090812-3-dk-2006.0077 · Cited by 10
Cited by
Developing the UVA/Padova Type 1 Diabetes Simulator: Modeling, Validation, Refinements, and Utility
Cobelli, C., & Kovatchev, B. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231195081 · Cited by 46
Self-citationLu, X., Cai, D., Liu, W., Ji, L., & Shi, D. (2025) · IEEE Transactions on Automation Science and Engineering · doi:10.1109/tase.2025.3548101 · Cited by 10
“…artificial pancreas (AP) [4] is developed to mimic the pattern of insulin secretion in the human pancreas, and numerous closed-loop control methods have been researched such as proportional-integral-derivative (PID) control [5], [6], model predictive control (MPC) [7], and fuzzy logic control [8].”
Evolution of the Artificial Pancreas: Components and Integration—CGMs, Insulin, and AP Systems
Bergenstal, R. M., Heller, A., Breton, M. D., Vigersky, R. A., Brown, S. A., Forlenza, G. P., Sherr, J. L., Hovorka, R., Russell, S. J., Damiano, E. R., et al. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251342239 · Cited by 10
Self-citationEvolution of the Artificial Pancreas: Components and Integration—CGMs, Insulin, and AP Systems
Bergenstal, R. M., Heller, A., Breton, M. D., Vigersky, R. A., Brown, S. A., Forlenza, G. P., Sherr, J. L., Hovorka, R., Russell, S. J., Damiano, E. R., et al. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2025.18801.rmb · Cited by 6
“85 In silico research has shown that PID control algorithms based on a two-compartment model of insulin kinetics would allow fully automated insulin delivery while using the peritoneal route.”
Self-citationAn Improved Adaptive Glucose Control Approach for Type 1 Diabetes with Temporal Dependence
Lei, J., Sun, X., Li, Y., Li, K., Zhang, S., Zeng, H., Qin, A. H., Chi, E., & Zhang, Y. (2024) · International Conference on Computational Intelligence and Applications (ICCIA) · doi:10.1109/iccia62557.2024.10719265 · Cited by 1
“In recent clinical products, proportional integral derivative (PID) control [4] and Basal-Bolus (BB) [5] control are most commonly used.”
Background
Metadata
- Authors
- Dalla Libera, A., Toffanin, C., Drecogna, M., Galderisi, A., Pillonetto, G., & Cobelli, C.
- Affiliations
- Department of Woman and Child's Health, University of Padova 1 , 35128 Padova, Italy
- University of Pavia (IT)
- University of Padua (IT)
- Corresponding author
- Cobelli, Claudio
- ORCID
- Venue
- APL Bioengineering
- Publisher
- AIP Publishing
- Published
- 2023-05-23
- Volume
- 7
- Issue
- 2
- Pages
- 026105-026105
- ISSN
- 2473-2877 (ISSN-L)
- PMC
- PMC10205143
- OpenAlex
- W4377292347
- Cited by
- 8
- References
- 26
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 2 · 2023: 1
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- creativecommons.org/licenses/by/4.0/ (tdm)
- Locations
- APL Bioengineering (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- European Commission (FORGETDIABETES-FET-EU951933)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- type 1 diabetes, artificial pancreas, glucose detection, hypoglycemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.